Average Co-Inventor Count = 6.88
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (62 from 4,925 patents)
2. Roche Glycart Ag (8 from 68 patents)
3. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,426 patents)
4. Roche Palo Alto LLC (1 from 322 patents)
5. F. Hoffmann-la Roche Ag (166 patents)
71 patents:
1. 12297263 - Humanized anti-Tau(PS422) antibodies and methods of use
2. 12297290 - Method for generating multispecific antibodies from monospecific antibodies
3. 12252533 - Anti-transferrin receptor antibodies with tailored affinity
4. 12227594 - Bispecific 2+1 contorsbodies
5. 12215152 - Humanized anti-human CD19 antibodies and methods of use
6. 12145994 - Bispecific antigen binding molecules capable of specific binding to CD40 and to fap
7. 12103967 - Bispecific anti-CCL2 antibodies
8. 12043651 - Compbody—a multivalent target binder
9. 12023378 - Covalently linked antigen-antibody conjugates
10. 11827711 - Antibodies binding to NKG2D
11. 11820816 - Anti-VEGF antibodies and methods of use
12. 11787873 - Bispecific HER2 antibodies and methods of use
13. 11739142 - Bispecific anti-CCL2 antibodies
14. 11680110 - Three-dimensional structure-based humanization method
15. 11673968 - Anti-BRDU antibodies and methods of use